DRSC - DRSC Integrative Ortholog Prediction Tool

back to: DIOPT - Ortholog Prediction Tool / DIOPT for Diseases and Traits

Protein Alignment Lrp4 and LRP2

DIOPT Version :9

Sequence 1:	NP_727914.1	Gene:	Lrp4 / 32552	FlyBaseID:	FBgn0030706	Length:	2009	Species:	Drosophila melanogaster
Sequence 2:	NP_004516.2	Gene:	LRP2 / 4036	HGNCID:	6694	Length:	4655	Species:	Homo sapiens

Alignment Length:	1783	Identity:	589/1783 - (33%)
Similarity:	871/1783 - (48%)	Gaps:	199/1783 - (11%)

- Green bases have known domain annotations that are detailed below.

  Fly   176 KPFRVNLAVLVQDDPSQPGETYSN-CQNSNESDENCNPEEDAVPNLQRDC--------------- 224
            |.:.||:            :|.|| |......:.:|:.....|||.||.|
Human   961 KSYDVNI------------QTGSNACNQPTHPNGDCSHFCFPVPNFQRVCGCPYGMRLASNHLTC 1013

  Fly   225 ----------EKTGIHVMCPRTFRCISKYWLCDGDDDCGDYSDETHCGARTN------------- 266
                      |:.|:.....:..||:..|:||||.|||.|.|||..||...|
Human  1014 EGDPTNEPPTEQCGLFSFPCKNGRCVPNYYLCDGVDDCHDNSDEQLCGTLNNTCSSSAFTCGHGE 1078

  Fly   267 ------------------------------CTDDQFECLNGFCIPRTWVCDGENDCKDFSDETHC 301
                                          |.|.|:.|.|..||.:.||||.:|||.|.|||.:|
Human  1079 CIPAHWRCDKRNDCVDGSDEHNCPTHAPASCLDTQYTCDNHQCISKNWVCDTDNDCGDGSDEKNC 1143

  Fly   302 NRT-TCTDEHFTCNDGYCISLAFRCDGEHDCNDNSDELKCAAVINSCPEGEFKCRGGLGGAGGPS 365
            |.| ||....|.|.:..||.|:|.|||:.||.|.|||:.|  |:| |...:|||..|
Human  1144 NSTETCQPSQFNCPNHRCIDLSFVCDGDKDCVDGSDEVGC--VLN-CTASQFKCASG-------- 1197

  Fly   366 GQCILNRFRCDGDNDCGDWSDEENCPQK-PSLCTSNEYKC-ADGTCIPKRWKCDKEQDCDGGEDE 428
            .:||....||||..||.|.|||..||.: |.:|.|:|::| .||.|||..|:||...||..|.||
Human  1198 DKCIGVTNRCDGVFDCSDNSDEAGCPTRPPGMCHSDEFQCQEDGICIPNFWECDGHPDCLYGSDE 1262

  Fly   429 -NDCGSLGSEHPLTCGSDEFTCNNGRCILKTWLCDGYPDCAAGEDEVECHLQCDLGQFLCPTKQ- 491
             |.|      .|.||.|..|.|:||.||.:.||||...||....||.:|..|    .|.||:.|
Human  1263 HNAC------VPKTCPSSYFHCDNGNCIHRAWLCDRDNDCGDMSDEKDCPTQ----PFRCPSWQW 1317

  Fly   492 NLTNLKICVHQKHICDGHNECPAGEDEADCPKERKCSE-PSPCEQLCIETTAGSNECACRLGYVM 555
            ......|||:...:|||..:||.|.||:.......||: ...|...|::...|: :|.|.||:::
Human  1318 QCLGHNICVNLSVVCDGIFDCPNGTDESPLCNGNSCSDFNGGCTHECVQEPFGA-KCLCPLGFLL 1381

  Fly   556 DKNKVNCTDIDECQYLTSPVCSQKCHNTMGSFKCSCETGYILRPDLRSCKALGG-AMTLLVANRW 619
            ..:...|.|||||..|.|  |||.|:|..|||:|||:|||:|..|.|:||.... ::.||||::.
Human  1382 ANDSKTCEDIDECDILGS--CSQHCYNMRGSFRCSCDTGYMLESDGRTCKVTASESLLLLVASQN 1444

  Fly   620 DIRRVTLS---NNRYSAIVKGLHNAIALDFHHRKGLMFWSDVSTDVIKMVYMNGTRVRDVIKWGL 681
            .|...:::   :|.||.:..|.: .:|:||....|.:||||.:.......:.|||..|.|....:
Human  1445 KIIADSVTSQVHNIYSLVENGSY-IVAVDFDSISGRIFWSDATQGKTWSAFQNGTDRRVVFDSSI 1508

  Fly   682 ESPGGIAVDWIHDLLFWTDSGTRRVEVSNFQGNLRTVIASYDLDKPRAIVVHP--GEALAFWSDW 744
            .....||:||:...|:|||.....:|||...|:.|||:.|.:|..||.:.:.|  .|.|.|||||
Human  1509 ILTETIAIDWVGRNLYWTDYALETIEVSKIDGSHRTVLISKNLTNPRGLALDPRMNEHLLFWSDW 1573

  Fly   745 GPNPKIERAYMDGTQRKVIISKGVTWPNGLAIDFPNSKIYWADAKQHAIECSNLDGSDRNKILST 809
            |.:|:||||.|||:.|.||:...:.||.||.||:||..:|:.|:....::..:.:|..|.:::::
Human  1574 GHHPRIERASMDGSMRTVIVQDKIFWPCGLTIDYPNRLLYFMDSYLDYMDFCDYNGHHRRQVIAS 1638

  Fly   810 HL--PHPFALTLFEDTMYWTDWNTKTVSAADKITGKEFRAVHENFHFPMDIHAYHPARQPEYADR 872
            .|  .||:|||||||::||||..|:.|..|:|..|.....|..|..:|:.|.|.||::||...:.
Human  1639 DLIIRHPYALTLFEDSVYWTDRATRRVMRANKWHGGNQSVVMYNIQWPLGIVAVHPSKQPNSVNP 1703

  Fly   873 CQKDRRGLRGGCSHLCL-----PNKTSRRCGCPIGLSLKEDGKTCKSTADKLVLVARRKDIRLRH 932
            |...|      ||||||     |:..|  |.||.|.||..|...|... |:..|:..|:.|....
Human  1704 CAFSR------CSHLCLLSSQGPHFYS--CVCPSGWSLSPDLLNCLRD-DQPFLITVRQHIIFGI 1759

  Fly   933 LRDNQADPNDVDMIVPLDNLKHAVALDWCSDTDFIYWTDVERSTINKAHLNGSYQQRVVHSNLVS 997
            ..:.:...||.  :||:..:::.:.:::.....:|||.: ....|::...:|:.:......::|.
Human  1760 SLNPEVKSNDA--MVPIAGIQNGLDVEFDDAEQYIYWVE-NPGEIHRVKTDGTNRTVFASISMVG 1821

  Fly   998 P-VGLALDWITDKLYWTDPSTNRIEVATTNGKMR---TLLIWE----KLYKPRDIVVNPIEGFMF 1054
            | :.||||||:..||.|:|.|..|||.|.:|.:|   ||:..:    .:..|..|.|:|..|.::
Human  1822 PSMNLALDWISRNLYSTNPRTQSIEVLTLHGDIRYRKTLIANDGTALGVGFPIGITVDPARGKLY 1886

  Fly  1055 WSDWGDD----PMIERANMDGHERVTITSKKLIYPNGLAIDYEKSKIYFVDGGTKTLENMNFDGS 1115
            |||.|.|    ..|..|||||....|:.:..|.:...:.:|.|:.|:|:...|...:|..|.||:
Human  1887 WSDQGTDSGVPAKIASANMDGTSVKTLFTGNLEHLECVTLDIEEQKLYWAVTGRGVIERGNVDGT 1951

  Fly  1116 GRQVILNGLGHPFGLDVNEGRVFWTDWDTKSVMSANKLTGKDTNVIIANSTDLMDIRVFHRTRRR 1180
            .|.::::.|.||:|:.|::..:::||...:.:...:|.||.:..|:..|..:|..::|:||.
Human  1952 DRMILVHQLSHPWGIAVHDSFLYYTDEQYEVIERVDKATGANKIVLRDNVPNLRGLQVYHRR--- 2013

  Fly  1181 IFNACDKLNG------GCSHLCLLNPTS-YTCACTVGVQLKEDRHTCSEGP-TQYILFAHRIDIR 1237
              ||.:..||      .|..:||..|.. ::|||..|.:|..|..:||  | ..:|:.:....||
Human  2014 --NAAESSNGCSNNMNACQQICLPVPGGLFSCACATGFKLNPDNRSCS--PYNSFIVVSMLSAIR 2074

  Fly  1238 QISLDF-DHLIDVVLPLPPIS----NAVALDVDRKTGYIYWSD-----TIENVIMSSSPDGLHVQ 1292
            ..||:. ||...:|    |::    ||:.:|||..:|:|||.|     ..:|.|....|||..:.
Human  2075 GFSLELSDHSETMV----PVAGQGRNALHVDVDVSSGFIYWCDFSSSVASDNAIRRIKPDGSSLM 2135

  Fly  1293 KIVGDSL-EN-PDGLVVDSIGRTIYWADA--GRHTIEVASLDGSNRHVIAYKDLESPRGLALDYE 1353
            .||...: || ..|:.||.:...:|:.:|  ....|||..::.:.|.|:....::.||.:.:|.:
Human  2136 NIVTHGIGENGVRGIAVDWVAGNLYFTNAFVSETLIEVLRINTTYRRVLLKVTVDMPRHIVVDPK 2200

  Fly  1354 AGLLFWTDWGHYRKIERSHLDGNERSRIVTANLGWPNGLSLDLKSKRIYWVDARLKTIDSCDYTG 1418
            ...|||.|:|...|||||.||...|:.:|:..:..|.||::|.....:||||..|..|......|
Human  2201 NRYLFWADYGQRPKIERSFLDCTNRTVLVSEGIVTPRGLAVDRSDGYVYWVDDSLDIIARIRING 2265

  Fly  1419 NQRKLIM--SSLHHPYALALSDDNIYWTDWKSKALHMT--ERRNISAKRDIITNIDGLMDIKIIY 1479
            ...::|.  |....||.:.:.:::|.|.|...|.:...  |..|......|..||:.|.|: .|:
Human  2266 ENSEVIRYGSRYPTPYGITVFENSIIWVDRNLKKIFQASKEPENTEPPTVIRDNINWLRDV-TIF 2329

  Fly  1480 QNQNQ-----STMKNACGNNNGNCSHLCLRNPSGYSCQCPIGLRLRQNSTTQCQNLPEDYLLIAL 1539
            ..|.|     ....|.|..|||.|||||...|..::.:|.......|:....|....|::|:.||
Human  2330 DKQVQPRSPAEVNNNPCLENNGGCSHLCFALPGLHTPKCDCAFGTLQSDGKNCAISTENFLIFAL 2394

  Fly  1540 RSGIGMISLNSGDFMDVVLPINGVHGAVVLDYHYRKNLLFFADVNLDVIRRVNLLNLT---ESKV 1601
            .:.:..:.|:..:.......||.....:.|||....:.::|.......:.:::...|:   .:..
Human  2395 SNSLRSLHLDPENHSPPFQTINVERTVMSLDYDSVSDRIYFTQNLASGVGQISYATLSSGIHTPT 2459

  Fly  1602 IVGTDVLTPNGIAVDWIADNLYWSDTDRKLIEVSRLDGSCRKRIVEDNLGDPRSLIVHPKKAYLF 1666
            ::.:.:.|.:|||.|||...:|:||...::|.....|||  .|.|...:..||::::.|.:.||:
Human  2460 VIASGIGTADGIAFDWITRRIYYSDYLNQMINSMAEDGS--NRTVIARVPKPRAIVLDPCQGYLY 2522

  Fly  1667 WSDWSSPAKIERSYLDGSNRTVIITSGIGFPTGLTIDFTNRRLLWADALEDNIGQVDFNGKRRQT 1731
            |:||.:.|||||:.|.|:.|..|:.|.:..|:|||:|:....|.|.||....|.:....|..|:.
Human  2523 WADWDTHAKIERATLGGNFRVPIVNSSLVMPSGLTLDYEEDLLYWVDASLQRIERSTLTGVDREV 2587

  Fly  1732 IVPYAPHPFGLTLFENSIFWTDWYNKSVYRSQKLARSGYGNPFEVRDALSGALDIRAVSLSRQPK 1796
            ||..|.|.|||||:...|:|||.|.:.:||:.|.  .|.|......:.||....|..|..:::.:
Human  2588 IVNAAVHAFGLTLYGQYIYWTDLYTQRIYRANKY--DGSGQIAMTTNLLSQPRGINTVVKNQKQQ 2650

  Fly  1797 SVNHCAQDNGGCTHLCLNRNVDYVCACP 1824
            ..|.|.|.||||:|:|........|.||
Human  2651 CNNPCEQFNGGCSHICAPGPNGAECQCP 2678

Known Domains:

Indicated by green bases in alignment.

Gene	Sequence	Domain	Region	External ID	Identity
Lrp4	NP_727914.1	LDLa	267..301	CDD:238060	18/33 (55%)
		LDLa	306..340	CDD:238060	16/33 (48%)
		LDLa	347..390	CDD:238060	17/42 (40%)
		LDLa	397..431	CDD:238060	18/35 (51%)
		LDLa	442..476	CDD:238060	16/33 (48%)
		LDLa	480..521	CDD:238060	15/41 (37%)
		FXa_inhibition	576..604	CDD:291342	17/27 (63%)
		LY	634..671	CDD:214531	10/36 (28%)
		NHL	<656..793	CDD:302697	56/138 (41%)
		LY	680..714	CDD:214531	11/33 (33%)
		NHL repeat	681..722	CDD:271320	15/40 (38%)
		NHL repeat	726..760	CDD:271320	19/35 (54%)
		LY	761..803	CDD:214531	13/41 (32%)
		NHL repeat	769..793	CDD:271320	10/23 (43%)
		FXa_inhibition	882..912	CDD:291342	15/34 (44%)
		LY	946..985	CDD:214531	6/38 (16%)
		NHL	<967..1142	CDD:302697	60/186 (32%)
		LY	988..1030	CDD:214531	18/42 (43%)
		NHL repeat	998..1037	CDD:271320	20/46 (43%)
		NHL repeat	1038..1080	CDD:271320	17/45 (38%)
		NHL repeat	1084..1119	CDD:271320	10/34 (29%)
		FXa_inhibition	1185..1220	CDD:291342	12/41 (29%)
		NHL	1260..>1445	CDD:302697	61/195 (31%)
		NHL repeat	1260..1296	CDD:271320	14/40 (35%)
		NHL repeat	1302..1337	CDD:271320	9/36 (25%)
		NHL repeat	1345..1383	CDD:271320	16/37 (43%)
		FXa_inhibition	<1499..1525	CDD:291342	7/25 (28%)
		LY	1600..1640	CDD:214531	12/39 (31%)
		LY	1643..1686	CDD:214531	17/42 (40%)
		LY	1688..1729	CDD:214531	13/40 (33%)
		FXa_inhibition	1801..>1825	CDD:291342	11/24 (46%)
LRP2	NP_004516.2	LDLa	28..62	CDD:238060
		LDLa	108..142	CDD:238060
		LDLa	149..179	CDD:238060
		LDLa	183..217	CDD:238060
		LDLa	222..256	CDD:238060
		LDLa	266..300	CDD:238060
		LY	415..457	CDD:214531
		LDL-receptor class B 1. /evidence=ECO:0000255\|PROSITE-ProRule:PRU00461	436..478
		LY	461..501	CDD:214531
		LDL-receptor class B 2. /evidence=ECO:0000255\|PROSITE-ProRule:PRU00461	479..521
		LY	503..548	CDD:214531
		LDL-receptor class B 3. /evidence=ECO:0000255\|PROSITE-ProRule:PRU00461	522..568
		LY	551..591	CDD:214531
		LDL-receptor class B 4. /evidence=ECO:0000255\|PROSITE-ProRule:PRU00461	569..613
		FXa_inhibition	663..704	CDD:291342
		LDL-receptor class B 5. /evidence=ECO:0000255\|PROSITE-ProRule:PRU00461	753..795
		LY	776..818	CDD:214531
		LDL-receptor class B 6. /evidence=ECO:0000255\|PROSITE-ProRule:PRU00461	796..837
		LDL-receptor class B 7. /evidence=ECO:0000255\|PROSITE-ProRule:PRU00461	838..881
		Ldl_recept_b	838..878	CDD:278487
		LY	864..904	CDD:214531
		LDL-receptor class B 8. /evidence=ECO:0000255\|PROSITE-ProRule:PRU00461	882..925
		FXa_inhibition	981..1013	CDD:291342	7/31 (23%)
		LDLa	1026..1060	CDD:238060	15/33 (45%)
		LDLa	1067..1101	CDD:238060	0/33 (0%)
		LDLa	1109..1143	CDD:238060	18/33 (55%)
		LDLa	1149..1183	CDD:238060	16/33 (48%)
		LDLa	1187..1222	CDD:238060	17/42 (40%)
		LDLa	1230..1264	CDD:238060	17/33 (52%)
		LDLa	1271..1305	CDD:238060	16/33 (48%)
		LDLa	1311..1344	CDD:197566	12/32 (38%)
		FXa_inhibition	1353..1388	CDD:291342	9/35 (26%)
		EGF_CA	1390..1429	CDD:214542	24/40 (60%)
		LY	1461..1500	CDD:214531	12/39 (31%)
		LDL-receptor class B 9. /evidence=ECO:0000255\|PROSITE-ProRule:PRU00461	1478..1520		14/41 (34%)
		LY	1501..1543	CDD:214531	14/41 (34%)
		LDL-receptor class B 10. /evidence=ECO:0000255\|PROSITE-ProRule:PRU00461	1521..1563		16/41 (39%)
		LY	1545..1589	CDD:214531	22/43 (51%)
		LDL-receptor class B 11. /evidence=ECO:0000255\|PROSITE-ProRule:PRU00461	1566..1609		24/42 (57%)
		LY	1591..1632	CDD:214531	13/40 (33%)
		LDL-receptor class B 12. /evidence=ECO:0000255\|PROSITE-ProRule:PRU00461	1610..1654		13/43 (30%)
		LDL-receptor class B 13. /evidence=ECO:0000255\|PROSITE-ProRule:PRU00461	1655..1695		15/39 (38%)
		LDL-receptor class B 14. /evidence=ECO:0000255\|PROSITE-ProRule:PRU00461	1790..1832		12/42 (29%)
		LDL-receptor class B 15. /evidence=ECO:0000255\|PROSITE-ProRule:PRU00461	1833..1882		17/48 (35%)
		LDL-receptor class B 16. /evidence=ECO:0000255\|PROSITE-ProRule:PRU00461	1883..1930		15/46 (33%)
		Ldl_recept_b	1883..1927	CDD:278487	14/43 (33%)
		LY	1911..1953	CDD:214531	11/41 (27%)
		LDL-receptor class B 17. /evidence=ECO:0000255\|PROSITE-ProRule:PRU00461	1931..1972		13/40 (33%)
		LDL-receptor class B 18. /evidence=ECO:0000255\|PROSITE-ProRule:PRU00461	1973..2013		10/39 (26%)
		FXa_inhibition	2022..2058	CDD:291342	10/35 (29%)
		NHL	2091..2300	CDD:302697	65/208 (31%)
		YncE	2092..>2285	CDD:225926	61/192 (32%)
		NHL repeat	2097..2142	CDD:271320	16/44 (36%)
		LDL-receptor class B 19. /evidence=ECO:0000255\|PROSITE-ProRule:PRU00461	2107..2156		17/48 (35%)
		NHL repeat	2147..2186	CDD:271320	10/38 (26%)
		LDL-receptor class B 20. /evidence=ECO:0000255\|PROSITE-ProRule:PRU00461	2157..2201		10/43 (23%)
		NHL repeat	2192..2231	CDD:271320	17/38 (45%)
		LDL-receptor class B 21. /evidence=ECO:0000255\|PROSITE-ProRule:PRU00461	2202..2245		18/42 (43%)
		NHL repeat	2235..2275	CDD:271320	12/39 (31%)
		LDL-receptor class B 22. /evidence=ECO:0000255\|PROSITE-ProRule:PRU00461	2246..2289		11/42 (26%)
		FXa_inhibition	2346..2382	CDD:291342	12/35 (34%)
		LDL-receptor class B 23. /evidence=ECO:0000255\|PROSITE-ProRule:PRU00461	2431..2477		8/45 (18%)
		LY	2459..2500	CDD:214531	14/42 (33%)
		LDL-receptor class B 24. /evidence=ECO:0000255\|PROSITE-ProRule:PRU00461	2478..2518		12/41 (29%)
LY	2500..2542	CDD:214531	17/41 (41%)
LDL-receptor class B 25. /evidence=ECO:0000255\|PROSITE-ProRule:PRU00461	2519..2562		20/42 (48%)
LY	2545..2585	CDD:214531	13/39 (33%)
LDL-receptor class B 26. /evidence=ECO:0000255\|PROSITE-ProRule:PRU00461	2563..2604		16/40 (40%)
LDL-receptor class B 27. /evidence=ECO:0000255\|PROSITE-ProRule:PRU00461	2605..2646		14/42 (33%)
FXa_inhibition	2655..2692	CDD:291342	11/24 (46%)
LDLa	2700..2732	CDD:238060
LDLa	2741..2775	CDD:238060
LDLa	2784..2817	CDD:238060
LDLa	2821..2854	CDD:197566
Ldl_recept_a	2863..2895	CDD:278486
LDLa	2905..2937	CDD:197566
LDLa	2948..2988	CDD:238060
LDLa	2993..3027	CDD:238060
LDLa	3031..3063	CDD:197566
LDLa	3075..3109	CDD:238060
cEGF	3132..3155	CDD:289433
vWFA	<3147..3190	CDD:294047
LY	3219..3260	CDD:214531
LDL-receptor class B 28. /evidence=ECO:0000255\|PROSITE-ProRule:PRU00461	3239..3281
LY	3262..3304	CDD:214531
Ldl_recept_b	3282..3329	CDD:278487
LDL-receptor class B 29. /evidence=ECO:0000255\|PROSITE-ProRule:PRU00461	3282..3324
LDL-receptor class B 30. /evidence=ECO:0000255\|PROSITE-ProRule:PRU00461	3333..3376
Ldl_recept_b	3333..3373	CDD:278487
LY	3358..3399	CDD:214531
LDL-receptor class B 31. /evidence=ECO:0000255\|PROSITE-ProRule:PRU00461	3377..3419
LY	<3408..3441	CDD:214531
LDL-receptor class B 32. /evidence=ECO:0000255\|PROSITE-ProRule:PRU00461	3420..3460
FXa_inhibition	3469..>3498	CDD:291342
LDLa	3512..3544	CDD:197566
LDLa	3553..3584	CDD:197566
LDLa	3594..3626	CDD:238060
LDLa	3634..3666	CDD:197566
LDLa	3682..3714	CDD:238060
LDLa	3719..3754	CDD:238060
LDLa	3759..3793	CDD:238060
LDLa	3798..3832	CDD:238060
LDLa	3885..3915	CDD:197566
LDLa	3928..3962	CDD:238060
EGF_CA	4007..4047	CDD:214542
LY	4141..4176	CDD:214531
LDL-receptor class B 33. /evidence=ECO:0000255\|PROSITE-ProRule:PRU00461	4154..4196
LDL-receptor class B 34. /evidence=ECO:0000255\|PROSITE-ProRule:PRU00461	4197..4240
Ldl_recept_b	4197..4237	CDD:278487
LY	4222..4264	CDD:214531
LDL-receptor class B 35. /evidence=ECO:0000255\|PROSITE-ProRule:PRU00461	4242..4283
SH3-binding. /evidence=ECO:0000255	4453..4462
PxLPxI/L motif 1, mediates interaction with ANKRA2. /evidence=ECO:0000250\|UniProtKB:P98158	4456..4461
PxLPxI/L motif 2, mediates interaction with ANKRA2. /evidence=ECO:0000250\|UniProtKB:P98158	4459..4464
Endocytosis signal. /evidence=ECO:0000255	4521..4526
Disordered. /evidence=ECO:0000256\|SAM:MobiDB-lite	4550..4574
Interaction with DAB2. /evidence=ECO:0000269\|PubMed:10769163	4589..4602
NPXY motif	4595..4598
SH2-binding. /evidence=ECO:0000255	4598..4601
Disordered. /evidence=ECO:0000256\|SAM:MobiDB-lite	4601..4655
SH3-binding. /evidence=ECO:0000255	4611..4622
Blue background indicates that the domain is not in the aligned region.

Information from Original Tools:

Tool	Simple Score	Weighted Score	Original Tool Information
Tool	Simple Score	Weighted Score	BLAST Result	Score	Score Type	Cluster ID
Compara	0	0.000	Not matched by this tool.
Domainoid	1	1.000	53	1.000	Domainoid score	I11391
eggNOG	0	0.000	Not matched by this tool.
Hieranoid	0	0.000	Not matched by this tool.
Homologene	0	0.000	Not matched by this tool.
Inparanoid	0	0.000	Not matched by this tool.
Isobase	0	0.000	Not matched by this tool.
OMA	0	0.000	Not matched by this tool.
OrthoDB	0	0.000	Not matched by this tool.
OrthoFinder	0	0.000	Not matched by this tool.
OrthoInspector	0	0.000	Not matched by this tool.
orthoMCL	1	0.900	-	-		OOG6_100345
Panther	0	0.000	Not matched by this tool.
Phylome	1	0.910	-	-
RoundUp	0	0.000	Not matched by this tool.
SonicParanoid	0	0.000	Not matched by this tool.
SwiftOrtho	1	1.000	-	-
TreeFam	0	0.000	Not matched by this tool.
User_Submission	0	0.000	Not matched by this tool.
	4	3.810